Introduction
Osteoarthritis (OA) is a common chronic joint disease projected to affect an astounding 18% of the population in the western world by the year 2020 (Lawrence et al., 1998) . In addition, it has a cost of $15.5 billion per year in the US alone, taking into account the accompanying disability and social consequences (Yelin and Callahan, 1995) . Current hypotheses of OA pathology and OA pain tend to be exclusive to either. Here we present a hypothesis that is an attempt to identify a common aetiology for both.
OA pathology
The features of OA constitute a group of conditions that are diagnosed upon common pathological and radiological characteristics (Felson et al., 1997) and are believed to be caused by material failure of the cartilage network leading to tissue breakdown (Poole, 1999) or by injury of chondrocytes with increased degradative responses (Aigner and Kim, 2002) .
OA pain
Pain has been defined as the primary symptom of OA (Creamer, 2000) . Physicians typically rely on scores of pain and measures of joint function to make treatment decisions for OA (Swagerty, Jr. and Hellinger, 2001 ), as pain rather than joint pathology is more pronounced in this disorder.
Immunologic mechanisms in OA
OA has been considered to primarily affect cartilage and bone. However, there is increasing awareness that all tissues of the synovial joint, including synovium, ligaments and nerve terminals, are likely affected by this complex disease. Moreover, OA has been described as a non-inflammatory degenerative condition that is characterized by the imbalance of articular cartilage degradation and repair. Traumatic injury of the joint, either acute sport injuries or chronic aging accumulation is the leading cause of this imbalance. But genetic factors also play a role in some OA. Surprisingly, C-reactive protein (CRP), a systemic marker of inflammation, is increased in serum in OA patients at early phases (Saxne et al., 2003b ; Sowers et al., 2002) although it has been suggested that inflammation is actually related to complication by crystalline arthritis (Rothschild and Martin, 2006) . This suggests the presence of low-grade inflammation at early stages of the disease process. Recently, the research of the genetic linkages and the innate immune activation in OA further supports a possible pathogenic role of inflammation and a "chronic wound repair" type of immunologic mechanisms in OA (Kato et (Jasin, 1985) . This suggests that antibodies are synthesized within the affected joint by infiltrating immune cells or that the cartilage is more permeable to immunoglobulins.
Toll-like receptors (TLRs)
TLRs are a group of pattern recognition receptors (Barton and Medzhitov, 2002), which gate the immune response. Up to now, a total of 13 TLRs have been identified -TLR1 to TLR10 in human; TLR1 to TLR13 (except TLR10) in murine (Beutler, 2005) . A highly specific pattern governs the TLR recognition of various microbial ligands. Each of these TLRs responds only to a limited number of microbial ligands summarized in Table 1 of  Akira and Takeda (2004) . TLRs adopt either the myeloid differentiation primary response gene 88 (MyD88)-dependent or MyD88-independent pathway following activation. TLR signalling pathways lead to the production of several critical transcription factors, including NF-κB, interferon regulatory factor (IRF) and activator protein-1 (AP-1). Three most common TLR-mediated signalling pathways are the MyD88-dependent and MyD88-independent release of NF-κB, and the MyD88-independent production of IRF. Each of TLRs seems to recruit different subsequent signalling pathways (Akira and Takeda, 2004). But detailed information remains unclear to us. Mollen et al. (2006) proposed the theory of "TLRs and danger signalling": During tissue stress or injury, a variety of damage-associated molecules are actively secreted by stressed cells, passively released from necrotic cells, or originally from the degradation of the extracellular matrix. These damage-associated molecular patterns are recognized by TLRs in a similar manner as that of exogenous pathogen-associated molecular patterns. A long list of damage-associated molecules have been proposed as putative endogenous TLR ligands (Beg, 2002) , including hyaluronan, heparin sulphate, fibrinogen, high-mobility group protein (HMGB1), HSP 60, host mRNA, host chromatin and small ribonucleoprotein particles as well. Therefore, TLRs seem to be critical players in determining the nature of tissue injure, and initiating corresponding signalling pathways that result in distinct forms of pain.
431
Increasing evidence supports TLR4 as the main TLR sensing tissue damage in that it responds to a couple of endogenous ligands, such as HSP 60, fibrinogen, heparin sulphate and hyaluronan (Johnson et TLR3 and TLR9 are known to recognize microbial nucleic acids. However, host nucleic acids are also capable of initiating immune response via TLR activation -chromatin can induce the production of anti-DNA antibodies via a TLR9-dependent mechanism (Leadbetter et al., 2002) . In Alzheimer's patients, TLR3 expression was identified in brains without previous viral infection . The up-regulation of TLR3 expression might partly be explained by the finding that RNA is a constituent in senile plaques (Marcinkiewicz, 2002) . The inflammatory nature of the disease may result from TLR3 activation by host RNA. Necrotic cells resulted from various processes including tissue injuries release host nucleic acids. Kariko et al. (2004) demonstrated that it was RNA released from necrotic cells that led to TLR3-dependent release of TNF-. Necrotic cell lysates lost the capability to stimulate TNF-release once they were pretreated with Benzonase, a potent and nonspecific nuclease that degrades all RNA into oligomers of 2-5 nucleotides in length.
TLR pathways in OA pathology
Age and joint trauma are two risk factors for the development and progression of OA. Endogenous damage-associated molecules, including hyaluronan, fibronectin, have been identified in OA in response to initial tissue injury. Hyaluronan is highly viscous polysaccharide found in the extracellular matrix, and is a major component of synovial fluid and cartilage, which plays an important role in the lubrication and shock absorption for the joint tissue. Its molecular weight/length is reduced in exercise and joint injury (Brown et al., 2007) . In OA, both of the concentration and molecular weight of hyaluronan are reduced (Dahl et al., 1985) . Hyaluronan fragments of specific sizes have been shown to promote angiogenesis and have immune regulatory effects mediated by the TLR-4 receptor (Taylor et al., 2004b ). However, TLR-4 responses initiated by bacterial product lipopolysaccharide (LPS) and endogenous product hyaluronan are different, due to the recruitment of different accessory molecules, CD14 for the LPS-TLR-4 response and CD44 for the hyaluronan-TLR-4 response (Taylor et al., 2007) . Fibronectin is another extracellular matrix component affected by both age and tissue injury, and the presence of fibronectin and a specific isoform containing the B sequence, Ed-B fibronectin, in osteoarthritic cartilage but not in normal cartilage has led to the suggestion that the isoform might play a role in extracellular matrix remodelling (Chevalier et al., 1996) . In addition to the traditional integrin-mediated pathways, certain splice variants of fibronectin are also capable of activating a TLR-4 dependant pathway (Lasarte et 
TLR bridges traumatic injury and OA pain
Chronic pain can arise from a wide variety of causes -arthritis pain, low back pain, migraine, cancer pain, post-herpetic neuralgia, diabetic neuropathy, and others. Currently, chronic pain is explained more or less on the basis of structural abnormalities, such as osteoarthritis or herniated disk (Omoigui, 2007a) . Chronic pain has not been able to be classified into well mechanism-based entities. To distinguish inflammatory pain from neuropathic pain is the best attempt so far. Hawker et al. (2008) revealed two distinct types of OA pain: an early predictable dull, aching, throbbing "background" pain and an unpredictable short episode of intense pain that develops later (Hawker et al., 2008) . During the progression of OA, pain evolves from the "background" pain that is use-related in early OA (Kidd, 2006) , to unpredictable short episodes of intense pain on top of the "background" One critical fact about chronic pain is that its nature is determined shortly after the initial insult. For example, nerve section induces neuropathic pain only, but never inflammatory pain, no matter how complicated the subsequent cytokine cascade is. Different types of tissue injury are associated with distinct forms of chronic pain. TLRs likely play an important role in the "judgment of pain" in various tissue injuries, as they are the most important interface initiating the release of cytokines following cellular response to distinct pathogen-or damage-associated molecular patterns, and they have limited yet highly specific subtypes associated with distinct intracellular signalling pathways. The notion that inflammatory mechanisms are underlying all pain syndromes was recently proposed in two review papers ( TLR and NF-κB pathway -Different adaptor molecules recruited by different TLRs result in differences in NF-κB activation. TLR signalling via the MyD88-dependent pathway leads to the early phase release of NF-κB. During TLR2 or TLR4 signalling, TIRAP/MAL is recruited to TIR domain, and then MyD88, whereas during TLR5, TLR7 or TLR9 signalling, MyD88 is recruited to TIR domain. Activation of MyD88-independent pathway downstream of TLR3 or TLR4 accounts for the late phase release of NF-κB, where TRIF is the key adaptor recruited. TLR and IFN-JAK-STAT pathway -Type I IFNs previously were found mainly due to the activation of the MyD88-independent pathway which triggers the expression of IFN-and chemokine genes (Sakaguchi et Kim et al., 1998; Ma et al., 2003) , changes in C neurons were also reported, but are less prominent than those in A neurons. Therefore, it seems that there are distinct changes in subgroups of DRG neurons in various chronic pain models resulted from different mechanisms, which can be regarded as pain manifestation at the neuronal level. Several TLRs have clearly established their correlation with hyperalgesia or allodynia. Compared with wild type mice, TLR2 knock-out mice showed reduced mechanical allodynia and thermal hyperalgesia after spinal nerve axotomy . Intrathecal administration of TLR3 antisense oligodeoxynucleotide (ODN) suppressed the spinal nerve ligation-induced tactile allodynia, whereas intrathecal injection of TLR3 agonist induced behavioural changes similar to the nerve-injury induced sensory hypersensitivity (Obata et al., 2008) . TLR4 knock-out mice and the rats treated with TLR4 antisense ODN both showed significantly attenuated mechanical allodynia and thermal hyperalgesia in L5 spinal nerve transection (Tanga et al., 2005) . TLR activation in microglia in spinal cord was proven to play a critical role in spinal nerve axotomy-induced sensory hypersensitivity (Kim et 
Conclusion
We propose a novel concept regarding the mechanism underlying the pain in OA induced by traumatic injuries. Following an initial trauma to the joint, two distinct yet interacting processes are initiated. One is neural injury of joint afferents and ensuing maladaptive changes of the nervous system, which results in pain in OA. The other is the cartilage degradation and bony changes in the joint, which generates characteristic pathology in OA. These two processes are likely initiated by damage-associated molecules produced during the initial joint injury, such as hyaluronan, fibronectin and proteoglycan aggrecan, mediated by pattern-recognition receptors like the TLRs. The TLR-dependent pathways lead to the activation of NF-K B and downstream transcription factors to produce various inflammatory and destructive mediators and autoantibodies. Thus, various downstream pathways, such as the MMP-mediated, ADAMITS-mediated, MAPK-mediated, are activated to generate a spectrum of osteoarthritic changes, both functional (pain) and structural (deficit in cartilage and bone deformity). TLRs, maybe other pattern-recognition receptors, are at the intersection of OA pathology and pain. 
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